Skip to main content
Aarti Industries Ltd logo

Aarti Industries Ltd — Investor Relations & Filings

Ticker · AARTIIND ISIN · INE769A01020 LEI · 335800JBE5SD89NHB831 BSE.NS Manufacturing
Open in API
Filings indexed 1,194 across all filing types
Latest filing 2022-09-26 Regulatory Filings
Country IN India
Listing BSE.NS AARTIIND

About Aarti Industries Ltd

https://www.aarti-industries.com/

Aarti Industries Ltd is a global manufacturer of specialty chemicals and pharmaceuticals, specializing in benzene-based derivatives. The company utilizes complex chemical processes such as chlorination, nitration, hydrogenation, and ammonolysis to produce a wide range of intermediates. Key products include nitrochlorobenzenes, dichlorobenzenes, phenylenediamines, and various sulfuric acid derivatives. These chemicals serve as critical inputs for the agrochemical, pharmaceutical, polymer, additive, surfactant, and pigment sectors. With a strong emphasis on research and development, the company operates integrated manufacturing complexes designed for process efficiency and environmental compliance. Its technical expertise allows for the production of high-purity chemicals used in crop protection, life-saving medicines, and advanced materials for industrial applications.

Recent filings

Filing Released Lang Actions
Annual General Meeting
Regulatory Filings Classification · 100% confidence The document contains only digital signatures by an individual named Raj Kumar Sarraf and no substantive content such as financial data, report details, or announcements. It appears to be an officer certification or attestation without any report or announcement content. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-09-26 English
Demerger
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the approval of a Scheme of Arrangement by the National Company Law Tribunal (NCLT) under Sections 230-232 of the Companies Act, 2013. It includes the NCLT order sanctioning the scheme of demerger between Aarti Industries Limited and Aarti Pharmalabs Limited, detailed legal and procedural information about the scheme, compliance with regulatory requirements, and the effect of the scheme on shareholders and creditors. The document is a formal regulatory announcement of a corporate restructuring event (demerger) approved by a tribunal, not a financial report or earnings release. It is not a proxy statement, voting result, or management change announcement. The content fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about a corporate action (scheme approval) and does not constitute a merger proxy statement or tender offer filing (MA), nor is it a capital/financing update (CAP) or delisting notice (DLST).
2022-09-23 English
Loss of share certificate
Regulatory Filings Classification · 100% confidence The document text is extremely short (90 characters) and contains only a digital signature with no substantive content or financial data. It does not contain any report, announcement, or detailed information. Given the lack of content, this is likely a regulatory filing or a certification-type document without financial data. According to the rules, such minimal content defaults to Regulatory Filings (RNS).
2022-09-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 100% confidence The document text is extremely short (90 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report or announcement text. Given the lack of content, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2022-09-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 100% confidence The document text is extremely short (90 characters) and contains only a digital signature with no substantive content or financial data. It does not contain any report, announcement, or detailed information. Given the lack of content, this is likely a regulatory filing or a certification-type document with no report attached. According to the rules, such minimal content defaults to Regulatory Filings (RNS).
2022-09-12 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short letter dated September 9, 2022, addressed to stock exchanges (BSE and NSE) reporting the outcome of an investor/analyst meeting held by the company's CFO. It references Regulation 30(6) of SEBI (LODR) Regulations, which pertains to disclosure of material events. The content is a brief notification of the meeting outcome without any detailed financial data, analysis, or presentation materials. The document length is only 1117 characters, indicating it is a short announcement rather than a full report or transcript. It does not contain financial statements or detailed discussion, so it is not an Interim Report, Earnings Release, or Call Transcript. It is also not a report publication announcement since it does not mention any report being published or attached. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a meeting with analysts, fulfilling disclosure requirements under SEBI regulations.
2022-09-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.